|

Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management

RECRUITINGN/ASponsored by Centre Francois Baclesse
Actively Recruiting
PhaseN/A
SponsorCentre Francois Baclesse
Started2025-10-24
Est. completion2027-09-15
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Treatment for cancers of the pharyngolarynx is mutilating, with major consequences for patients' lives in terms of physical and functional after-effects. The psycho-social consequences are also significant, notably the metamorphosis of identity linked to the disease and its treatment, which alters the patient's self-image. Initial feedback from patients who have been able to benefit from adapted oncoesthetics (OEA) is overwhelmingly positive. This study will assess the feasibility of oncoesthetics and describe any obstacles.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patient aged 18 or over
* Neoplastic location: oropharynx, oral cavity, hypopharynx, larynx, nasal cavity, salivary glands, cavum, sinus.
* Patient due to start oncological treatment (recurrence authorized)
* Patient fluent in French.
* Affiliation with a social security scheme
* Signature of informed consent prior to any specific procedure linked to the study
* Treatment with curative intent

Exclusion Criteria:

* Breast-feeding or pregnant patient
* Any associated medical or psychological condition that could compromise the patient's ability to participate in the study
* Patient deprived of liberty, under guardianship, or subject to a legal protection measure or unable to express their consent.
* Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.

Conditions4

Aerodigestive Tract CancerCancerOncologySuportive Care

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.